Biotin Supplements and Lab Test Interference: A Hidden Risk
Last reviewed: 21 mars 2026 11:56
Biotin (vitamin B7, also known as vitamin H) is one of the most popular supplements for skin, hair, and nail health, available over the counter in doses ranging from 1,000 to 10,000 mcg — which is 333 to 3,333 times the adequate intake of 30 mcg per day for adults. While biotin supplementation has a favorable safety profile in terms of direct toxicity (no tolerable upper intake level has been established because no adverse effects have been reliably documented), it harbors a lesser-known but potentially dangerous risk: significant interference with many common laboratory blood tests. The FDA issued a safety communication in 2017 warning about this interference after at least one death was attributed to a missed diagnosis of heart attack due to a falsely normal troponin result in a patient taking high-dose biotin.
The interference occurs because many immunoassay platforms used in clinical laboratories employ streptavidin-biotin chemistry as part of their detection system. When a patient has high biotin blood levels from supplementation, the excess biotin competes with the biotin-labeled reagents in the assay, producing erroneous results. The direction of interference depends on the assay format. In competitive immunoassays (used for many hormones including thyroid hormones, cortisol, vitamin D, and testosterone), excess biotin causes falsely elevated results. In sandwich immunoassays (used for TSH, troponin, parathyroid hormone, and tumor markers), excess biotin causes falsely decreased results. This means biotin supplementation can simultaneously produce falsely high free T4 and falsely low TSH, mimicking the laboratory pattern of hyperthyroidism in a person with completely normal thyroid function.
The clinical consequences of biotin interference can be severe. Falsely low troponin results could cause a heart attack to be missed in an emergency department evaluation. Falsely abnormal thyroid test results could lead to unnecessary medication changes, radioactive iodine treatment, or even thyroid surgery. Falsely abnormal hormone panels could prompt unnecessary referrals and invasive procedures. Falsely low tumor markers could provide false reassurance in cancer surveillance. The problem is compounded by the fact that many patients do not think to mention biotin supplementation (or other supplements containing biotin, such as multivitamins and prenatal vitamins) when asked about medications, and many clinicians do not routinely ask about supplement use or consider biotin interference when interpreting laboratory results.
Practical recommendations for biotin supplement users include the following. First, always inform your healthcare provider and the laboratory that you are taking biotin supplements before any blood tests. Second, discontinue biotin supplementation at least 72 hours before scheduled blood work — some experts recommend 48 hours for doses up to 5,000 mcg and up to one week for higher doses, as biotin's half-life and clearance time depend on renal function. Third, be aware that biotin is present in many combination supplements marketed for hair, skin, and nails, as well as in some B-complex vitamins, multivitamins, and prenatal formulations. Fourth, if you receive unexpected or contradictory lab results while taking biotin, discuss the possibility of biotin interference with your healthcare provider before making any medical decisions based on those results. Fifth, consider whether biotin supplementation is actually necessary for you — clinical biotin deficiency is exceedingly rare in individuals eating a varied diet, and evidence that biotin supplements improve skin, hair, or nails in biotin-replete individuals is limited.
The interference occurs because many immunoassay platforms used in clinical laboratories employ streptavidin-biotin chemistry as part of their detection system. When a patient has high biotin blood levels from supplementation, the excess biotin competes with the biotin-labeled reagents in the assay, producing erroneous results. The direction of interference depends on the assay format. In competitive immunoassays (used for many hormones including thyroid hormones, cortisol, vitamin D, and testosterone), excess biotin causes falsely elevated results. In sandwich immunoassays (used for TSH, troponin, parathyroid hormone, and tumor markers), excess biotin causes falsely decreased results. This means biotin supplementation can simultaneously produce falsely high free T4 and falsely low TSH, mimicking the laboratory pattern of hyperthyroidism in a person with completely normal thyroid function.
The clinical consequences of biotin interference can be severe. Falsely low troponin results could cause a heart attack to be missed in an emergency department evaluation. Falsely abnormal thyroid test results could lead to unnecessary medication changes, radioactive iodine treatment, or even thyroid surgery. Falsely abnormal hormone panels could prompt unnecessary referrals and invasive procedures. Falsely low tumor markers could provide false reassurance in cancer surveillance. The problem is compounded by the fact that many patients do not think to mention biotin supplementation (or other supplements containing biotin, such as multivitamins and prenatal vitamins) when asked about medications, and many clinicians do not routinely ask about supplement use or consider biotin interference when interpreting laboratory results.
Practical recommendations for biotin supplement users include the following. First, always inform your healthcare provider and the laboratory that you are taking biotin supplements before any blood tests. Second, discontinue biotin supplementation at least 72 hours before scheduled blood work — some experts recommend 48 hours for doses up to 5,000 mcg and up to one week for higher doses, as biotin's half-life and clearance time depend on renal function. Third, be aware that biotin is present in many combination supplements marketed for hair, skin, and nails, as well as in some B-complex vitamins, multivitamins, and prenatal formulations. Fourth, if you receive unexpected or contradictory lab results while taking biotin, discuss the possibility of biotin interference with your healthcare provider before making any medical decisions based on those results. Fifth, consider whether biotin supplementation is actually necessary for you — clinical biotin deficiency is exceedingly rare in individuals eating a varied diet, and evidence that biotin supplements improve skin, hair, or nails in biotin-replete individuals is limited.